Interconnections between apoptotic, autophagic and necrotic pathways: Implications for cancer therapy development
Bleeker, J.C., et al., Ketonesters as a Possible Novel Therapeutic Option for Patients With Fatty Acid Oxidation Disorders [abstract]
Innovation is focused on long-acting injectables, oral formulations, and fixed-dose combinations
Acetyl-L-Carnitine 1500mg *
After a 48-hour exposure to the mixtures, there was a significant decrease in cell viability linked to an increase in oxidative stress, alterations in mitochondrial membrane potential, and an increase in caspase-3 activity
However, why in the world would you want to take such a dangerous medication when much better options exist